Related Experiment Videos
[Diastolic heart failure. Treatment].
A Cohen Solal1, E Salengro, P Garçon
1Service de Cardiologie, Hôpital Beaujon, 100, boulevard du Général Leclerc, 92118 Clichy.
Presse Medicale (Paris, France : 1983)
|November 17, 2001
Summary
Current treatment for diastolic heart failure lacks consensus. Focus remains on managing underlying causes and triggers, as specific drug therapies show limited clinical evidence for this condition.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Diastolic heart failure treatment lacks established consensus.
- Various drugs show potential in experimental settings but lack clinical validation.
Purpose of the Study:
- To review current therapeutic options for diastolic heart failure.
- To evaluate the efficacy of experimental and clinical treatments.
Main Methods:
- Review of experimental trials and clinical practice guidelines.
- Analysis of drug classes including nitrate derivatives, ACE inhibitors, ARBs, and others.
Main Results:
- No definitive consensus on optimal treatment for diastolic heart failure.
- Experimental drugs like ACE inhibitors and ARBs show promise for left ventricular function but are not yet indicated.
- Clinical practice relies on diuretics and treating underlying causes like hypertension and ischemic heart disease.
Conclusions:
- Optimal treatment for diastolic heart failure remains undefined.
- Management focuses on addressing precipitating factors and underlying cardiac conditions.
- Further research is needed to establish evidence-based therapeutic strategies.